Solid-state analysis for pharmaceuticals: Pathways to feasible and meaningful analysis
Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Dokumenter
- Fulltext
Forlagets udgivne version, 1,27 MB, PDF-dokument
The solid state of matter is the preferred starting point for designing a pharmaceutical product. This is driven by both patient preferences and the relative ease of supplying a solid pharmaceutical product with desired quality and performance. Solid form diversity is increasingly prevalent as a crucial element in designing these products, which underpins the importance of solid-state analytical methods. This paper provides a critical analysis of challenges related to solid-state analytics, as well as considerations and suggestions for feasible and meaningful pharmaceutical analysis.
Originalsprog | Engelsk |
---|---|
Artikelnummer | 115649 |
Tidsskrift | Journal of Pharmaceutical and Biomedical Analysis |
Vol/bind | 236 |
Antal sider | 7 |
ISSN | 0731-7085 |
DOI | |
Status | Udgivet - 2023 |
Bibliografisk note
Funding Information:
This work has been supported by NordForsk (Oslo, Norway) - Nordic University Hub project Nordic POP (Patient Oriented Products; project number 85352 ).
Publisher Copyright:
© 2023 The Authors
ID: 366305159